ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,267.84
      -0.74%
      US Tech 100
      18,135.20
      -0.51%
      Dow Jones
      39,065.26
      -1.53%
      Brent Oil
      81.28
      -0.31%
      Bitcoin
      67,741.74
      -1.97%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      Symbol: 
      		Date:
      Sort by:
      DateTimeSourceHeadlineSymbolCompany
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:KNTKKinetik Holdings Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGYSAgilysys Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:YUMCYum China Holdings Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MEDSTRxADE HEALTH Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EQEquillium Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABVCABVC BioPharma Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:RZCReinsurance Group of America Incorporated
      05/23/20245:00PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LILMWLilium NV
      05/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:EOGEOG Resources Inc
      05/23/20245:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:FMSTWForemost Lithium Resource and Technology Ltd
      05/23/20245:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:LEGNLegend Biotech Corporation
      05/23/20245:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CURIWCuriosityStream Inc
      05/23/20245:00PMBusiness WireGenmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:GMABGenmab AS
      05/23/20245:00PMBusiness WireMerck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024
      05/23/20245:00PMGlobeNewswire Inc.IN8bio Announces INB-200 Phase 1 Study Data in Newly Diagnosed Glioblastoma to be Presented at the 2024 ASCO Annual MeetingNASDAQ:INABIN8bio Inc
      05/23/20245:00PMBusiness WireLegend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHANASDAQ:LEGNLegend Biotech Corporation
      05/23/20245:00PMBusiness WireSOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
      05/23/20245:00PMGlobeNewswire Inc.Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients Non-Responsive to Immune Checkpoint Inhibitor (ICI) Treatment at 2024 ASCO Annual MeetingNASDAQ:CADLCandel Therapeutics Inc
      05/23/20245:00PMGlobeNewswire Inc.Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual MeetingTG:2GHMerus NV
      05/23/20245:00PMGlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
      05/23/20245:00PMGlobeNewswire Inc.Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024NASDAQ:EVAXEvaxion Biotech AS
      05/23/20245:00PMBusiness WireObsidian Therapeutics Announces Positive Clinical Data from OBX-115 in Patients with Advanced Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
      05/23/20245:00PMGlobeNewswire Inc.Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual MeetingNASDAQ:MURAMural Oncology PLC
      05/23/20245:00PMBusiness WireDentalcorp Announces Annual General Meeting Voting ResultsTSX:DNTLdentalcorp Holdings Ltd
      05/23/20245:00PMGlobeNewswire Inc.Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024
      05/23/20245:00PMGlobeNewswire Inc.MAQUIA CAPITAL ACQUISITION CORPORATION AND IMMERSED INC. MUTUALLY AGREE TO TERMINATE BUSINESS COMBINATION AGREEMENTNASDAQ:MAQCMaquia Capital Acquisition Corporation
      05/23/20245:00PMGlobeNewswire Inc.Kymera Therapeutics to Present New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual MeetingNASDAQ:KYMRKymera Therapeutics Inc
      05/23/20245:00PMBusiness WireKlaviyo to Present at the William Blair Growth Stock ConferenceNYSE:KVYOKlaviyo Inc
      05/23/20245:00PMGlobeNewswire Inc.Merus Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO® Annual MeetingNASDAQ:MRUSMerus NV
      05/23/20245:00PMBusiness WireOrca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual Meeting